Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
Dongkui Song et al.
JOURNAL OF PATHOLOGY (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Caroline Pettenati et al.
NATURE REVIEWS UROLOGY (2018)
Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer
Nirmish Singla et al.
WORLD JOURNAL OF UROLOGY (2017)
Role of Aspirin in Patients with Bladder Cancer Receiving Intravesical Bacillus Calmette-Guerin: A Prospective, Observational Study
Rupesh Gupta et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2017)
Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments
Carson Ka-Lok Lo et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
Effect of statin use on outcomes of non-muscle-invasive bladder cancer
Joseph J. Crivelli et al.
BJU INTERNATIONAL (2013)
The Effect of Fibrin Clot Inhibitors on the Immunomodulatory Efficacy of Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer
Michael J. Lipsky et al.
UROLOGY (2013)
Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis
Ting-Ting Tang et al.
JOURNAL OF LIPID RESEARCH (2011)
Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-GuErin
Jason R. Gee et al.
BJU INTERNATIONAL (2009)
Intravesical Bacille Calmette-Guerin Therapy for Non-Muscle-Invasive Bladder Cancer: Effects of Concurrent Statin Therapy
Ted A. Skolarus et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Fibrin Clot Inhibitor Medication and Efficacy of Bacillus Calmette-Guerin for Bladder Urothelial Cancer
Stephen A. Boorjian et al.
JOURNAL OF UROLOGY (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
An analysis of the effect of statin use on the efficacy of bacillus Calmette-Guerin treatment for transitional cell carcinoma of the bladder
Ryan K. Berglund et al.
JOURNAL OF UROLOGY (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Use of statins and outcome of BCG treatment for bladder cancer
Paul Hoffmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus Calmette-Guerin for superficial bladder tumors
M Eto et al.
UROLOGIA INTERNATIONALIS (2005)
Share Paper
